GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Galderma Group AG (CHIX:GALDz) » Definitions » Common Stock

Galderma Group AG (CHIX:GALDZ) Common Stock : CHF3 Mil (As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Galderma Group AG Common Stock?

Galderma Group AG's quarterly common stock stayed the same from . 20 (CHF0 Mil) to Jun. 2023 (CHF0 Mil) but then increased from Jun. 2023 (CHF0 Mil) to Jun. 2024 (CHF3 Mil).

Galderma Group AG Common Stock Historical Data

The historical data trend for Galderma Group AG's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galderma Group AG Common Stock Chart

Galderma Group AG Annual Data
Trend
Common Stock

Galderma Group AG Semi-Annual Data
Jun23 Jun24
Common Stock - 2.68

Galderma Group AG Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Galderma Group AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Galderma Group AG (CHIX:GALDz) » Definitions » Common Stock
Comparable Companies
Traded in Other Exchanges
GALDY:USA GDERF:USA GALD:Switzerland
Address
Zahlerweg 10, Zug, CHE, 6300
Website
https://www.galderma.com
Galderma was formed in 1981 as a joint venture between Nestle and L'Oreal. It subsequently became a subsidiary of Nestle, called Nestle Skin Health, before being carved out and launched as a standalone company in 2019, acquired by a consortium led by Sweden-based EQT fund. The company went public in March 2024 and is listed on the SIX Swiss exchange. Galderma's science-based portfolio spans multiple dermatology categories, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. It derives around 45% of net sales from the US and employs around 6,600 people.

Galderma Group AG Headlines

No Headlines